Sheldon X. Kong
Bayer (United States)(US)First Affiliated Hospital of Henan University(CN)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Health Systems, Economic Evaluations, Quality of Life, Inflammatory mediators and NSAID effects, Chronic Kidney Disease and Diabetes
Most-Cited Works
- → Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?(2004)801 cited
- → A literature review of the epidemiology and treatment of acute gout(2003)276 cited
- → Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system(2017)222 cited
- → Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption(1998)192 cited
- → The SF-36 Health Survey as a Generic Outcome Measure in Clinical Trials of Patients With Osteoarthritis and Rheumatoid Arthritis(1999)183 cited
- → Rasch analysis of the Western Ontario MacMaster Questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia